Article
Precision Oncology in Cholangiocarcinoma: Current Standards and Future Directions
2026-08-19
Abstract excerpt
The therapeutic landscape of cholangiocarcinoma (CCA) has undergone a paradigm shift towards precision oncology following recognition of its molecularly heterogenous landscape and rapid development of novel targeted therapeutics. Although outcomes remain poor, particularly in locally advanced or metastatic disease, comprehensive genomic profiling has identified multiple clinically actionable genomic alterations, l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2a18e6e-ea17-53a9-86bf-7a8e5c839f5d
- DOI
- 10.20944/preprints202608.1301.v1
